COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information
Authors
Davide, M.Kamposioras, K.
Lampriani, T.
Mario, D.
Berardino, B.
Nadia, H.
Carl, S.
Joanna, N.
Dimitrios, T.
Flippo, A.
Hassan, H.
Antonios, V.
Konstantinos, P.
Stefanie, C.
Lazar, P.
Jindrich, K.
Andres, R.
Katarina, A.
Junlin, Y.
Lovey, J.
Primoz, S.
Haytham, S.
Ranveig, R.
Marzanna, C.
Olalla, S. C.
Natalia, C.
Ramon, A. M.
Giovanna, A. A.
Farsid, A.
Radu, V.
Erjeta, R.
D, T.
Chirstos, C.
Irina, I.
Igor, D.
Branka, P.
Francesco, C.
Iglika, M.
Natalija, D. P.
Cvetka, G. K.
Elena, T.
Pantelis, K.
Panagiotis, N.
Ioanna, G.
Stefania, G.
Salih, Y.
Er, Ö.
Yasmina, C.
Kumaran, G.
Orges, S.
Aasim, Y.
Gono, P.
Apostolidis, K.
Tolia, M.
Affiliation
Department Medical Oncology, University Hospital of Ioannina, Ioannina, GreeceIssue Date
2021
Metadata
Show full item recordAbstract
Background: Covid-19 vaccination has started in the majority of the countries at the global level. Cancer patients are at high risk for infection, serious illness, and death from COVID-19 and need vaccination guidance and support. Guidance availability in the English language only is a major limit for recommendations’ delivery and their application in the world’s population and generates information inequalities across the different populations. Methods: Most of the available COVID-19 vaccination guidance for cancer patients was screened and scrutinized by the European Cancer Patients Coalition (ECPC) and an international oncology panel of 52 physicians from 33 countries. Results: A summary guidance was developed and provided in 28 languages in order to reach more than 70 percent of the global population. Conclusion: Language barrier and e-guidance availability in the native language are the most important barriers when communicating with patients. E-guidance availability in various native languages should be considered a major priority by international medical and health organizations that are communicating with patients at the global level.Citation
Davide M, Kamposioras K, Lampriani T, Mario D, Berardino B, Nadia H, et al. COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information. Rev Recent Clin Trials. 2021.Journal
Rev Recent Clin TrialsDOI
10.2174/1574887116666211028145848PubMed ID
34967300Additional Links
https://dx.doi.org/10.2174/1574887116666211028145848Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.2174/1574887116666211028145848
Scopus Count
Collections
Related articles
- Offering onsite COVID-19 vaccination to high-risk obstetrical patients: initial findings.
- Authors: Hirshberg JS, Huysman BC, Oakes MC, Cater EB, Odibo AO, Raghuraman N, Kelly JC
- Issue date: 2021 Nov
- Kūpuna "Older Adults" COVID-19 Vaccination Efforts in Hawai'i: Barriers and Successes.
- Authors: Ibrao M, Cadirao CM, Ariyoshi D, Lopez KS, Ilagan L, Braun KL
- Issue date: 2023 Nov
- COVID-19 vaccination rates, intent, and hesitancy in patients with solid organ and blood cancers: A multicenter study.
- Authors: Nguyen M, Bain N, Grech L, Choi T, Harris S, Chau H, Freeman D, Kwok A, Williams J, McCartney A, Webber K, Day D, Segelov E
- Issue date: 2022 Dec
- Challenges and Opportunities for COVID-19 Vaccines in Patients with Cancer.
- Authors: Kuderer NM, Hill JA, Carpenter PA, Lyman GH
- Issue date: 2021 Mar
- Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage.
- Authors: Christie A, Brooks JT, Hicks LA, Sauber-Schatz EK, Yoder JS, Honein MA, CDC COVID-19 Response Team
- Issue date: 2021 Jul 27